1. Home
  2. ETSY vs KYMR Comparison

ETSY vs KYMR Comparison

Compare ETSY & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Etsy Inc.

ETSY

Etsy Inc.

HOLD

Current Price

$78.00

Market Cap

7.0B

ML Signal

HOLD

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$99.69

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETSY
KYMR
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.4B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ETSY
KYMR
Price
$78.00
$99.69
Analyst Decision
Hold
Strong Buy
Analyst Count
26
26
Target Price
$62.50
$107.72
AVG Volume (30 Days)
3.0M
768.4K
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.60
N/A
Revenue
$441,231,000.00
$39,211,000.00
Revenue This Year
N/A
$10.61
Revenue Next Year
$3.44
$8.17
P/E Ratio
$124.82
N/A
Revenue Growth
20.90
N/A
52 Week Low
$44.00
$36.88
52 Week High
$76.52
$105.00

Technical Indicators

Market Signals
Indicator
ETSY
KYMR
Relative Strength Index (RSI) 75.82 74.83
Support Level $51.56 $76.40
Resistance Level N/A $103.00
Average True Range (ATR) 2.68 4.66
MACD 0.56 2.50
Stochastic Oscillator 88.89 84.32

Price Performance

Historical Comparison
ETSY
KYMR

About ETSY Etsy Inc.

Founded in 2005, Etsy operates a leading global marketplace, connecting roughly 87 million active buyers and 6 million sellers of unique, handmade, and vintage goods. In fiscal 2025, the firm generated $2.9 billion in revenue and almost $12 billion in gross merchandise sales. The firm monetizes its marketplace primarily through transaction fees and advertising, with core categories spanning homeware, jewelry, apparel, and craft supplies. The US drives 74% of sales, though its core geographic reach extends to the UK, Germany, Canada, and Australia.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: